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Abstract
Purpose To evaluate the accuracy and technical success
of positioning a radiofrequency ablation (RFA) electrode in
osteoid osteomas by use of a new real-time needle guid-
ance technology combining cone-beam computed tomog-
raphy (CT) and fluoroscopy.
Materials and Methods Percutaneous RFA of osteoid
osteomas was performed in five patients (median age
18 years), under general anesthesia, with the use of cone-
beam CT and fluoroscopic guidance for electrode posi-
tioning. The outcome parameters were technical success,
meaning correct needle placement in the nidus; accuracy
defined as the deviation (in mm) from the center of the
nidus; and clinical outcome at follow-up.
Results In all five cases, positioning was possible within
3 mm of the determined target location (median nidus size
6.8 mm; range 5–10.2 mm). All procedures were techni-
cally successful. All patients were free of pain at clinical
follow-up. No complications were observed.
Conclusion Real-time fluoroscopy needle guidance based
on cone-beam CT is a useful tool to accurately position
radiofrequency needles for minimally invasive treatment of
osteoid osteomas.
Keywords Osteoid osteoma  Radiofrequency ablation 
Real-time needle guidance
Introduction
Osteoid osteoma is a benign skeletal tumor that accounts for
approximately 10% of all benign bone tumors [1, 2]. Patients
with osteoid osteoma are mostly children or young adults
and more frequently male. Although lesions can occur in
almost every bone, osteoid osteomas are usually found in
the lower extremity with a prevalence for femur and tibia. A
striking radiological feature is the radiolucent nidus sur-
rounded by an area of dense osteosclerosis [3]. This nidus
has low growth potential and usually has a diameter smaller
than 15 mm, which is considered small [1, 3]. This small size
leads to difficulties in visualizing and targeting the nidus.
Invasive treatments include complete surgical resection,
percutaneous excision by hollow drills, and percutaneous
radiofrequency ablation (RFA). RFA involves the use of
thermal coagulation of the nidus to induce necrosis in the
osteoid osteoma. Rosenthal et al. [4] compared RFA to
surgical treatment. Although equivalent treatment outcome
was concluded, RFA was preferred because of shorter
hospital stay and shorter recovery time. Various needle
guidance approaches have been described as minimally
invasive and effective methods for the percutaneous treat-
ment of osteoid osteomas, such as computed tomographic
(CT) guidance [1, 2, 5, 6], fluoroscopic guidance [7], or
ultrasonographic guidance [8].
Although CT is a good technique to visualize the nidus
and its surrounding soft tissue, it has its limitations in
needle guidance. Real-time guidance is not possible unless
CT–fluoroscopy is used with an associated increase in
radiation dose. Furthermore, the planned needle path has to
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be within the imaging plane, which restricts the angle of
approach. Especially for procedures requiring a double-
angulated approach, this is a limiting factor.
Real-time needle guidance is possible with fluoroscopy.
However, the visualization of the targeted nidus is subop-
timal, and the images offer no information about the sur-
rounding soft tissues [7]. Osteoid osteoma is difficult to
distinguish on ultrasound, so therefore it is not the modality
of choice [9, 10].
Limitations of the above-mentioned techniques have
resulted in the development of a novel real-time needle
guidance technique for tracking and navigation, combining
cone-beam CT and fluoroscopic guidance for needle
placement in the interventional radiology suite [11]. The
purpose of this report is to describe our experience with
this guidance technique for accurate positioning of radio-
frequency electrodes to ablate small targets, such as osteoid
osteomas.
Materials and Methods
Patients
RFA was performed on five patients, four male and one
female (median age 18 years; range 5–51 years), with
osteoid osteoma. The diagnosis was based on severe pain
that did not respond to aspirin, and radiological features.
Lesions were located in corpus L5 (n = 1), acetabulum
(n = 1), femur (n = 2), and tibia (n = 1). The median
nidus size was 6.8 mm (range 5–10.2 mm). Patient and
nidus characteristics are summarized in Table 1. In one
patient, an earlier unsuccessful attempt was made to access
the nidus under conventional CT guidance with a drill.
The study was exempted for approval by the institu-
tional review board because the commercially available
system is used in standard clinical practice in our hospital
for interventional procedures.
Procedure
All procedures were performed with the patient under
general anesthesia in the interventional room under aseptic
conditions. General anesthesia is necessary because RFA
treatment is extremely painful.
To determine the exact location of the nidus, a cone-
beam CT scan was performed with the Allura Xper FD-20
system (Philips Medical Systems, Best, The Netherlands).
Subsequently, the system’s XperGuide functionality, nee-
dle planning, and navigation software tool, which creates
an overlay of live fluoroscopy and 3D soft tissue images
(Philips XperCT), was used in the next phases of the
procedure. First, the 3D volume reconstructed from the
XperCT images was used to plan the needle trajectory from
the skin entry point to the center of the nidus (target
location). The determined path was projected onto real-
time fluoroscopy images together with an overlay of the
XperCT images to allow exact needle placement on the
patient’s skin and constant monitoring and adjustments
during needle progression. The software also calculates the
position of the X-ray tube to view the entry point of the
needle on the skin. This was used to automatically move
the gantry and precisely align the 11-gauge introducer
(StarBurst Access System; RITA Medical Systems,
Mountain View, CA) to the determined path. The pro-
gression of the needle into the patient was followed in real
time under fluoroscopic guidance after selecting the pro-
gression view, which rotates the gantry 90 perpendicularly
to the trajectory. By using the guiding views, the introducer
was placed at the bone cortex. Thereafter, the Bonopty
Penetration Set or Extended Drill (Radi Medical Systems,
Uppsala, Sweden) was used to drill through the cortex
towards the nidus. A second XperCT scan was performed
to confirm the correct position of the drill. When the nidus
was reached, the drill was replaced by the StarBurst SDE
radiofrequency electrode (17 gauge, 12 cm; RITA Medical
Systems) connected to the radiofrequency generator model
1500 of RITA (power of 50 W). Two grounding pads,
placed on the patient’s upper legs during patient prepara-
tion, were used to disperse the heat. The electrode tip was
placed as near as possible to the center of the nidus, and its
temperature was increased to 85C. This temperature was
maintained for 4 minutes, ablating the nidus in a sphere
with a diameter of 2 cm to ensure ablation of the entire
nidus. After ablation, the electrode and introducer were
withdrawn, and a bandage was applied.
The procedure was regarded as technically successful if
the electrode was placed within the nidus and the drill had
followed the predetermined path toward the planned target.
The accuracy of the needle placement is defined as the
deviation (in mm) from the center of the nidus and the
planned path.
Table 1 Nidus sizes and deviations for all patients
Patient no. Sex Age
(years)
Nidus size
(mm)
Deviation from nidus
center (mm)
1 M 13 5 0
2 M 50 5 2.3
3 M 51 6.8 1.8
4 M 18 10.2 0.6
5 F 5 9.9 0
Median 18 6.8 0.6
W. M. H. Busser et al.: Real-Time Needle Guidance RFA 181
123
Patients were adminitsered pain medication to control
postprocedural pain and were discharged from the hospital
on the same day unless the pain was too severe.
According to our clinical practice, clinical follow-up
was 2 months post-procedure during an outpatient visit to
assess the clinical outcome of the procedure in terms of
pain and the need for additional treatments.
Results
The nidus sizes were 5, 5, 6.8, 9.9, and 10.2 mm (Fig. 1).
The needle was placed within the nidus in all five cases,
with a maximum deviation of 2.3 mm (range 0–2.3 mm;
Table 1) from the determined target location (the center of
the nidus) indicating technical success (Fig. 2A, B). Each
nidus was reached with the radiofrequency electrode at the
first attempt. RFA was successfully performed in all five
patients.
The intraprocedural XperCT images indicated that for
all patients there was no change in body position during the
procedure. No complications were observed in any of the
patients.
At clinical follow-up, all patients were free of pain and
needed no further treatment with nonsteroidal anti-inflam-
matory drugs, which we regarded as clinical success.
In four of the five patients, the needle trajectories were
in the axial plane. For the fifth patient, an oblique trajectory
was required to reach the nidus located in L5. In the entry
point view position, the C arm was rotated -27 and
angulated -32. In the progression view, the C arm was
rotated -27 and angulated 58 (Fig. 2B).
Discussion
Percutaneous RFA has already been shown to be effective
in treating osteoid osteomas. Other authors report initial
clinical success rates (n = 12–47) of 77–94% and sec-
ondary success rates after repeated radiofrequency treat-
ments of 92–100% [5, 6, 12, 13]. The results of this initial
experience of our small series of patients with XperGuide
to aid in exact needle placement show an initial clinical
success rate of 5 out of 5.
Fig. 1 Computed tomographic image of the osteoid osteoma located
in L5 in patient 5, which required a double-angulated approach
Fig. 2 a XperCT image with needle placed in the nidus located in L5
(axial plane). b XperCT image with the needle in place. The needle
has followed the planned double-angulated trajectory into the nidus
(rotation -27, angulation 58)
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Dupuy et al. [14] have shown that RFA in bones has
significant effect in pain reduction at follow-up at 1 and
3 months. Our follow-up at 2 months is therefore sufficient
to determine clinical success in terms of pain relief.
During needle progression toward a particular target,
body position changes can negatively affect precise tar-
geting. This can be minimized as the XperCT scan enables
path determination during the procedure. For our patients,
who were treated under general anesthesia, no changes in
body position were observed between XperCT scans
acquired during planning and after needle insertion,
thereby allowing accurate localization and targeting of the
nidus without the need for additional path realignment.
Overlaying the XperCT images with the predetermined
path and real-time fluoroscopy images has several benefits.
First, the optimal path is planned by allocating the target
and skin entry point so as to avoid important anatomical
structures such as vessels and nerves. This allows confident
and continuous adjustments to the introducer so that the
correct path is followed. The entry point view and pro-
gression views perpendicular to the path are automatically
calculated by the system, thereby attaining the optimal
gantry position. The views obtained with the software
allow monitoring of drill progression in relation to the
predetermined path and the underlying soft tissue, which
possibly has the advantage of limiting unnecessary tissue
damage and damage to critical structures.
In our experience, XperGuide also provides the benefit
of being able to access the nidus from any direction. The
path can be planned in any direction through the entire
three-dimensional volume for either the shortest or safest
access. When CT is used for needle guidance, the trajectory
is limited to the axial plane or the scanning plane with the
gantry at the maximum tilt of approximately 25–30. In
our fifth patient, an axial path would not have provided
access to the nidus located in L5 without damaging nerve
roots. A gantry angulation of -32 was used for the entry
point view in this particular case and 58 for the progres-
sion view.
To fully assess the additional value of XperGuide in
treatments such as RFAs, further extended studies are
required.
The results of our study indicate that the combined
needle guidance technology is a useful tool for precise
needle positioning in small osteoid osteomas for treatment
with RFA.
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